VYNDALINK Trademark

Trademark Overview

On Thursday, February 14, 2019, a trademark application was filed for VYNDALINK with the United States Patent and Trademark Office. The USPTO has given the VYNDALINK trademark a serial number of 88301744. The federal status of this trademark filing is REGISTERED as of Tuesday, August 3, 2021. This trademark is owned by Wyeth LLC. The VYNDALINK trademark is filed in the Personal, Legal & Social Services category with the following description:

Providing patient advocate services in the field of cardiovascular diseases and disorders
vyndalink

General Information

Serial Number88301744
Word MarkVYNDALINK
Filing DateThursday, February 14, 2019
Status700 - REGISTERED
Status DateTuesday, August 3, 2021
Registration Number6441600
Registration DateTuesday, August 3, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 21, 2019

Trademark Statements

Pseudo MarkVYNDA LINK
Goods and ServicesProviding patient advocate services in the field of cardiovascular diseases and disorders

Classification Information

International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, March 8, 2019
Primary Code045
First Use Anywhere DateThursday, August 8, 2019
First Use In Commerce DateWednesday, July 31, 2019

Trademark Owner History

Party NameWyeth LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressNew York, NY 100012192
Party NameWyeth LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressNew York, NY 10017
Party NameWyeth LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Monday, March 27, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 27, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 27, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 27, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 27, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 3, 2021REGISTERED-PRINCIPAL REGISTER
Thursday, July 1, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, June 30, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Sunday, June 27, 2021STATEMENT OF USE PROCESSING COMPLETE
Friday, June 25, 2021USE AMENDMENT FILED
Friday, June 25, 2021TEAS STATEMENT OF USE RECEIVED
Thursday, June 24, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 23, 2021SOU EXTENSION 4 GRANTED
Friday, June 18, 2021SOU EXTENSION 4 FILED
Wednesday, June 23, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, June 18, 2021TEAS EXTENSION RECEIVED
Tuesday, December 22, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 18, 2020SOU EXTENSION 3 GRANTED
Friday, December 18, 2020SOU EXTENSION 3 FILED
Friday, December 18, 2020TEAS EXTENSION RECEIVED
Thursday, June 18, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 16, 2020SOU EXTENSION 2 GRANTED
Tuesday, June 16, 2020SOU EXTENSION 2 FILED
Tuesday, June 16, 2020TEAS EXTENSION RECEIVED
Tuesday, December 24, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 20, 2019SOU EXTENSION 1 GRANTED
Friday, December 20, 2019SOU EXTENSION 1 FILED
Friday, December 20, 2019TEAS EXTENSION RECEIVED
Tuesday, July 16, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 21, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 21, 2019PUBLISHED FOR OPPOSITION
Wednesday, May 1, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, March 28, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 21, 2019ASSIGNED TO EXAMINER
Friday, March 8, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 18, 2019NEW APPLICATION ENTERED

Related Keywords

vyndalink cardiovascular diseases disorders field services patient advocate providing